| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/20/2008 | CN101125130A Indian chrysanthemum effervescent preparation and preparation method thereof |
| 02/20/2008 | CN101125128A Sustained-release tablet composition of pramipexole |
| 02/20/2008 | CN101125127A Artemisinin derivatives freeze-dried preparation and preparation method |
| 02/20/2008 | CN101125124A Method for preparing lipophilic medicine solid dispersion |
| 02/20/2008 | CN101125123A Red sage root A magnesium injection preparation and preparation method thereof |
| 02/20/2008 | CN100369630C Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 02/20/2008 | CN100369606C Inclusion containing raltitrexed and preparation |
| 02/20/2008 | CN100369604C Drop pill type eye drip fluid of chloramphenicol, and preparation method |
| 02/20/2008 | CN100369603C Product recipe for bee glue soft capsule inclusion |
| 02/19/2008 | US7332586 Active agent and a nuclear localization signal and methods of modulating gene expression and protein expression employing the nanoparticle delivery vehicle. A representative method includes providing a nanoparticle delivery vehicle comprising |
| 02/19/2008 | US7332566 Biocompatible crosslinked polymers with visualization agents |
| 02/19/2008 | US7332528 DRI nasal sprays |
| 02/19/2008 | US7332527 Cross-linked ionic core micelles |
| 02/19/2008 | US7332523 TNP-470 polymer conjugates and use thereof |
| 02/19/2008 | US7332503 Aporphine esters and their use in therapy |
| 02/19/2008 | US7332477 Visible light and ultraviolet (UV) light sensitive composition for DNA transfer comprising an acid sensitive gene transfer agent, a photoacid generator, and a bioactive agent |
| 02/19/2008 | US7332468 8-tetradecenal as fragrance and flavoring substance |
| 02/19/2008 | US7332465 Alkoxylates exhibiting low residual alcohol content |
| 02/19/2008 | US7332332 Mixture comprising sodium and potassium ions for use in transfer of exogenous nucleotide sequences into cells; genetic engineering and heterologous gene expression |
| 02/19/2008 | US7332230 Multilayer preparation in film form, consisting of hydrophilic polymers, for the rapid release of active ingredients |
| 02/19/2008 | US7332181 Composition for managing diabetes, obesity, and hyperlipidemia and associated methods |
| 02/19/2008 | US7332180 Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same |
| 02/19/2008 | US7332178 lactose-free infant formula; stability can be achieved without reliance upon complex antioxidation systems, and instead relies upon the use of selectively high ascorbyl palmitate concentrations, alone or in combination with at least about 300 ppm by weight of cystine and/or cysteine |
| 02/19/2008 | US7332177 Administering melatonin to ameliorate or prevent symptoms of hypertension developing in a patient who is resistant to the antihypertensive effect of an antihypertensive compound |
| 02/19/2008 | US7332164 Heterobifunctional polymeric bioconjugates |
| 02/19/2008 | US7332155 comprising comb copolymers based on acryloyldimethyltaurine |
| 02/19/2008 | US7331951 Devices and methodologies useful in body aesthetics |
| 02/19/2008 | US7331339 Methods and systems for operating an aerosol generator |
| 02/19/2008 | CA2431565C Pharmaceutical compositions based on anticholinergics and ciclesonide |
| 02/19/2008 | CA2383977C Stably preserving oxygen infusion |
| 02/19/2008 | CA2348024C Granular, free-flowing pharmaceutical composition, and straw-like dosage form for oral administration thereof |
| 02/19/2008 | CA2338901C Prevention of migraine recurrence |
| 02/19/2008 | CA2338629C Carrageenan compositions, and processes for their production |
| 02/19/2008 | CA2310049C Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases |
| 02/19/2008 | CA2301889C Water-soluble dry compositions |
| 02/19/2008 | CA2289702C High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| 02/19/2008 | CA2286756C Use of zinc hyaluronate against peptic ulcer |
| 02/19/2008 | CA2277207C Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and a preparation containing dichlorobenzyl alcohol |
| 02/19/2008 | CA2273240C Compositions and methods for treating or preventing inflammatory diseases |
| 02/19/2008 | CA2267668C Method for enhancing the efficiency of gene transfer with stem cell factor polypeptide |
| 02/19/2008 | CA2265893C Oily patches for external use containing diclofenac sodium |
| 02/19/2008 | CA2263795C Chemically modified polypeptides |
| 02/19/2008 | CA2259584C Plasters containing isosorbide dinitrate |
| 02/19/2008 | CA2237023C Improved formulation for administration of steroid compounds |
| 02/19/2008 | CA2220008C Composition and method for tumor imaging |
| 02/19/2008 | CA2197210C Intravenous alendronate formulations |
| 02/14/2008 | WO2008019254A2 Reagents, methods and systems to suppress pro-inflammatory cytokines |
| 02/14/2008 | WO2008019115A2 Formulations for parenteral delivery of compounds and uses thereof |
| 02/14/2008 | WO2008018825A1 Oral polyvinyl alcohol capsules comprising proton pump inhibitors |
| 02/14/2008 | WO2008018592A1 External preparation comprising prostaglandin derivative |
| 02/14/2008 | WO2008018569A1 Pharmaceutical composition |
| 02/14/2008 | WO2008018561A1 Process for production of spherical granule containing slightly water-soluble substance |
| 02/14/2008 | WO2008018556A1 Tablet |
| 02/14/2008 | WO2008018555A1 HBsAg PARTICLE HAVING LOW ANTIGENICITY AND METHOD FOR PRODUCTION THEREOF |
| 02/14/2008 | WO2008018371A1 Oral disintegrating tablet having masked bitter taste and method for production thereof |
| 02/14/2008 | WO2008018086A1 Mouth dissolving pharmaceutical or nutraceutical composition |
| 02/14/2008 | WO2008017867A2 Antiretroviral solid oral composition with at least one water insoluble polymer |
| 02/14/2008 | WO2008017603A1 G-csf site-specific mono-conjugates |
| 02/14/2008 | WO2008017507A2 Nanoparticle nucleic acid bonding compound conjugates forming i-motifs |
| 02/14/2008 | WO2008017335A2 Starch silica co-precipitate, method for preparing the same and use thereof |
| 02/14/2008 | WO2008017334A2 Microemulsified drug formulation |
| 02/14/2008 | WO2008017277A2 Polymeric conjugates of doxorubicin with ph-regulated release of the drug and a method of preparing |
| 02/14/2008 | WO2007140371A3 Antibodies and immunoconjugates and uses therefor |
| 02/14/2008 | WO2007140272A3 Controlled release of phenolic opioids |
| 02/14/2008 | WO2007135224A3 Method for storing silica-based material, package produced with the method and use of package for packaging of silica-based products |
| 02/14/2008 | WO2007115381B1 Solid dispersion of poorly soluble drugs in graft copolymers |
| 02/14/2008 | WO2007113531A3 Topical drug delivery |
| 02/14/2008 | WO2007093840A3 Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract |
| 02/14/2008 | WO2000041670A3 Pharmaceutical forms and methods for penetration continuity |
| 02/14/2008 | US20080039931 Hydrophilic shape memory insertable medical articles |
| 02/14/2008 | US20080039816 Carbohydrate-Encapsulated Quantum Dots for Bilogical Imaging |
| 02/14/2008 | US20080039533 Bioactive Compositions Comprising Triazines |
| 02/14/2008 | US20080039532 Compounds For Specific Viral Target |
| 02/14/2008 | US20080039516 Composition of Solifenacin or Salt Thereof for Use in Solid Formulation |
| 02/14/2008 | US20080039443 Manipulation of brain CDP-diacylglycerol and uses thereof |
| 02/14/2008 | US20080039422 Vitamin B12-Containing Compositions and Methods of Use |
| 02/14/2008 | US20080039396 Freeze drying an aliquot of an aqueous solution blood factor such as antihemophilic factor or blood-coagulation factor IX in the presence of trehalose stabilizer wherein the aliquot is free of albumin; hemophilia treatment |
| 02/14/2008 | US20080039373 Pegylated Factor VII Glycoforms |
| 02/14/2008 | US20080039371 Erythropoietin Liquid Formulation |
| 02/14/2008 | US20080039366 Administering insulin, sodium citrate and phospholipid to respiratory tract |
| 02/14/2008 | US20080038717 Enrichment method for variant proteins with altered binding properties |
| 02/14/2008 | US20080038403 Weight management system for obese animals |
| 02/14/2008 | US20080038356 Spray freeze-dried compositions |
| 02/14/2008 | US20080038353 Polymer Based Nano-Carriers For The Solubilization And Delivery Of Hydrophobic Drugs |
| 02/14/2008 | US20080038344 Solid Pharmaceutical Preparation |
| 02/14/2008 | US20080038342 Stable Pharmaceutical Composition Comprising an Ace Inhibitor |
| 02/14/2008 | US20080038341 Direct Compression Formulation And Process |
| 02/14/2008 | US20080038340 Solid dosage form of enteric solid dispersion and method for producing the same |
| 02/14/2008 | US20080038339 Solid dosage form comprising solid dispersion and method for producing the same |
| 02/14/2008 | US20080038328 Pasting Preparation |
| 02/14/2008 | US20080038326 Multilayered Dosing Systems |
| 02/14/2008 | US20080038321 Prophylactic/therapeutic compositions for liver diseases |
| 02/14/2008 | US20080038315 Process for agent retention in biological tissues |
| 02/14/2008 | US20080038310 Coating comprising an elastin-based copolymer |
| 02/14/2008 | US20080038298 Medicament and System for the Percutaneous Preparation of Medicaments |
| 02/14/2008 | US20080038292 comprises alkali metal salt, alkaline earth metal salt, and citrate/phosphate buffer; improved stability |
| 02/14/2008 | US20080038291 Method to reduce the physiologic effects of drugs on mammals |
| 02/14/2008 | US20080038281 Model membrane systems |
| 02/14/2008 | US20080038209 Nicotine Delivery Product and Method for Producing It |
| 02/14/2008 | US20080038203 Compositions and Methods for Topical Diagnostic and Therapeutic Transport |